High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status

Author(s):
Kortekaas, K.E.; Santegoets, S.J.; Abdulrahman, Z. (0000-0001-9079-0293); Ham, V.J. van; Tol, M. van der; Ehsan, I.; Doom, H.C. van; Bosse, T.; Poelgeest, M.I.E. van; Burg, S.H. van der (0000-0002-6556-0354)
Published
2019
Publication type
Article / Letter to editor
Vulvar cancerTumor microenvironmentImmunotherapyT cellsPD-1
Date issued
2019-09-03
Language
English
Is part of
Journal for ImmunoTherapy of Cancer (2019), No. 1
hdl
1887/120408
doi
10.1186/s40425-019-0712-z